Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-027121

Chief Medical Officer sold 2,000 shares at $44.50 ($89,000)

  • Chief Medical Officer acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BALDO LANCE Chief Medical Officer 2021-04-14 Option exercise +2,000 $7.80 $15,600 24,894 D: show line 1 in the form
BALDO LANCE Chief Medical Officer 2021-04-14 Sale −2,000 $44.50 $89,000 22,894 D: show line 2 in the form
Open-market sales · 2,000 sh · avg $44.50 · $89,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BALDO LANCE Chief Medical Officer 2021-04-14 Option exercise · Stock Option (Right to Buy) −2,000 339,250 D: show line 3 in the form
Loading xslF345X03/doc4.xml…